|
Match
|
Document |
Document Title |
|
|
7605288 |
Heat shock protein 90 inhibitors
Novel compounds useful for inhibiting the 90 kDa heat shock proteins containing a quinone-like moiety and a di-hydroxy phenol like moiety, similar to geldanamycin and radicicol.
|
|
|
RE40259 |
Alpha-aminoamide derivatives useful as analgesic agents
The present invention relates to novel and known alpha-aminoamide compounds, to a process for their preparation, to pharmaceutical composition containing them and to their use as therapeutic...
|
|
|
7312368 |
Method for selective reduction of aromatic compounds
A method for the selective reduction of an aromatic compound. The present invention provides a method for pre-venting the reduction of at least one halogen substituted aromatic ring of an aromatic...
|
|
|
7265245 |
Compounds useful for the treatment of diseases associated with the formation of amyloid fibrils
The present invention provides new amyloidogenesis inhibiting compounds of formula (I):
in which
R 1 is a —NR a R b group, where R a and R b , independently, are a hydrogen atom or...
|
|
|
7253318 |
Benzyloxy derivatives as MAOB inhibitors
The invention relates to compounds of the formula
and their pharmaceutically acceptable salts wherein
R 1 , R 2 , R 3 , R 4 , R 5 ,
n, m, and o are as defined in the specification. The...
|
|
|
7223888 |
Mu opioid receptor ligands: methods of use and synthesis
Novel compounds and compositions including those compounds, as well as methods of using and making the compounds are herein described. The compounds are useful in therapeutic applications,...
|
|
|
7208630 |
Heat shock protein 90 inhibitors
Novel compounds useful for inhibiting the 90 kDa heat shock proteins containing a quinone-like moiety and a di-hydroxy phenol like moiety, similar to geldanamycin and radicicol.
|
|
|
7196119 |
Development of new selective estrogen receptor modulators
The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen...
|
|
|
7138546 |
Compounds and compositions for delivering active agents
Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
7053071 |
Induction of apoptosis in cancer cells
The present invention provides compounds that are inducers or inhibitors of apoptosis or apoptosis preceded by cell-cycle arrest. In addition, the present invention provides pharmaceutical...
|
|
|
7045660 |
Compounds as PDE IV and TNF-inhibitors
This invention is directed to a [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a pharmaceutically acceptable salt thereof, which is useful for...
|
|
|
6951884 |
Fluorobenzamides and uses thereof
The invention relates to fluorobenzamide derivatives of the formula
wherein R 1 , R 2 , R 3 R 4 , R 5 , R 6 and R 7 are as defined herein. =,
The compounds of the invention are selective...
|
|
|
6900354 |
3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives
The invention relates to 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives, for example, deriviatives of the formula
wherein A is selected from
R 1 , R 3 , R...
|
|
|
6777442 |
Diphenyl derivatives
The present invention relates to compounds of the general formula (I) in which X represents O, S, SO, SO 2 , CH 2 , CHF, CF 2 or NR 8 , and Z represents a group of the formula in which A...
|
|
|
RE38506 |
Potent inducers of terminal differentiation and methods of use thereof
The present invention provides the compound having the structure: wherein each of R 1 and R 2 are independently the same as or different from each other; when R 1 and R 2 are the same, each...
|
|
|
6703421 |
Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure
A method for prevention or treating myocarditis, dilated cardiomyopathy and heart failure comprising administering to a patient in need of such treatment a NF-κB inhibitor in a therapeutically...
|
|
|
6693208 |
Compounds and compositions for delivering active agents
Amino acid derivative as carrier compounds and compositions which are useful in the delivery of active agents are provided. The active agents can be a peptide, mucopolysaccharide, carbohydrate, or...
|
|
|
6610883 |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X...
|
|
|
6586475 |
β-amyloid protein production/secretion inhibitors
A compound of the formula: wherein Ar is an aromatic group; X and Y are a bivalent group selected from —O—, —S—, —CO—, —SO 2 —, —NR 8 —, —CONR 8 —, SO 2 NR 8 and...
|
|
|
6576632 |
Biaryl compounds useful as anticancer agents
The present invention relates to compounds of formula I and to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 10 , R 11 , b, m, n, p...
|
|
|
6521663 |
Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors
Phenyl acetamide compounds are described, including compounds of Formula I: or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R 3 -R 6 , R 11 , B, Y and W are set forth...
|
|
|
6403649 |
Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
The present invention provides cydopentane heptanoic acid, 2-cycloalkyl or arylalkyl compounds, which may be substituted in the 1-position with amino, amido, ether or ester groups, e.g., a 1-OH...
|
|
|
6395787 |
Ocular hypotensive lipids
Compounds of Formula 1, where the symbols are as defined in the specification, are useful as ocular hypotensive agents but do not exert their activity through the FP prostaglandin receptor. In...
|
|
|
6207852 |
Smooth muscle spasmolytic agents, compositions and methods of use thereof
The present invention relates to smooth muscle spasmolytic agents, pharmaceutical compositions containing them and method of using said compounds and compositions for the treatment of urinary...
|
|
|
6121255 |
Phloroglucide derivatives and their pharmceutical use
A phloroglucide derivative having the following formula: ##STR1## wherein Q is halogen; X is CH 2 or CO; Y is cephalosporin having a formula of ##STR2## wherein Ph is phenyl, Ac is acetoxy, or...
|
|
|
6083987 |
Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
A phenylenediamine derivative or a salt thereof in accordance with the present invention is expressed by the following formula 1: ##STR1## wherein A represents a group expressed by --CO--, --CH 2 ...
|
|
|
6057342 |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
The present application describes amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt forms thereof,...
|
|
|
6013827 |
Compounds
This invention relates to componds of formula I ##STR1## which are useful as PDE IV inhibitors and for treating diseases related thereto.
|
|
|
5948418 |
Sulfur-based amides and bis-amides useful against skin disorders
Novel sulfhydryl group-containing amides and disulfide group-containing bis-amides useful for treating or preventing an abnormal biological condition or a disease, and/or improving the texture or...
|
|
|
5945557 |
Benzyloxy substituted aromatics and their use as fungicides and insecticides
Compounds with fungicidal and insecticidal properties having formula ##STR1## wherein A is N or CH; V is O or NH; m and n are the integers 0 and 1, provided that m+n is 0 or 1; X is independently...
|
|
|
5945454 |
2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
Novel 2(4-substituted)-benzylamino-2-methyl-propanamides compounds, having CNS activity, of general formula (I) wherein: n is zero, 1, 2 or 3; X is --O--, --S--, --CH 2 -- or --NH--; each of R and...
|
|
|
5935978 |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also...
|
|
|
5925646 |
Heterocyclic aryl-, alkyl- and cycloalkylacetamides
The heterocyclic aryl-, alkyl- and cycloalkylacetamides are prepared by reacting the appropriately substituted acetic acids with amines, if appropriate in complexed form. The heterocyclic aryl-,...
|
|
|
5916922 |
Phenyl glyoxamides as SPLA2 inhibitors
A class of novel phenyl glyoxamides is disclosed together with the use of such compounds for inhibiting sPLA 2 mediated release of fatty acids for treatment of conditions such as septic shock.
|
|
|
5900432 |
Therapeutic N-(4-benzoyl-2-methyl-phenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propana mides
Compounds of formula I: ##STR1## wherein, ring C, A--B, R 1 , n, R 2 , and R 3 have any of the meanings given in the specification, and their pharmaceutically acceptable salts are useful in the...
|
|
|
5880156 |
Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical or diagnostic, and pharmaceutical containing them Benzoylguanidines of the formula I ##STR1## are...
|
|
|
5827891 |
HIV protease inhibtors
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These...
|
|
|
5783602 |
Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents
The invention relates to leukotriene-B 4 derivatives of general formula I, ##STR1## in which R 1 represents CH 2 OH, CH 3 , CF 3 COOR 4 CONR 5 R 6 , and R 3 symbolizes H; C 1 -C 14 ...
|
|
|
5763610 |
Composition and processes for treating subterranean formations
A composition comprising a nitrogen-containing olefinic compound and a process for using the nitrogen-containing olefinic compound to produce a water-soluble polymer which has applications in a...
|
|
|
5753715 |
2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
The invention relates to cyclohexenyl antibacterial compounds of the formula I: ##STR1## and pharmaceutical compositions containing the compounds, methods for their production and use.
|
|
|
5750784 |
Method for effecting vasodilation with (1,5-inter) aryl prostaglandin derivatives
The present invention provides a method of effecting vasodilation, comprising: administering to a warm blooded animal in need of such treatment, an effective amount of a (1,5-inter) aryl...
|
|
|
5747539 |
Fluorine-containing benzoylguanidines
Fluorine-containing benzoylguanidines of the formula I ##STR1## in which R 1 , R 2 and R 3 have the meanings indicated, and their physiologically acceptable salts, have antiarrhythmic properties...
|
|
|
5728737 |
N-alkoxy-amidine derivatives
The present invention relates to novel N-alkoxy-arnidine derivatives of the formula (I), to a process for their preparation and to their use as pesticides. In addition, the invention also relates...
|
|
|
5721276 |
Arylalkyl(thio)carboxamides
The invention relates to a compound selected from those of formula (I): ##STR1## in which A, B, X and R 1 are as defined in the description, and medicinal product containing the same useful for...
|
|
|
5693611 |
Cyclic peptide antifungal agents
Provided are pharmaceutical formulations, and methods of inhibiting fungal and parasitic activity using a compound of formula I ##STR1## wherein: R', R", R'", R x1 , R x2 , R y1 , R y2 , R y3 , R...
|
|
|
5677303 |
Enolethers and their use as a fungicide
Enolethers and thioenolethers of formula I ##STR1## are disclosed. The compounds are useful for combatting phytopathogenic fungi.
|
|
|
5559134 |
Leukotriene-B.sub.4 antagonists, process for their production and their use as pharmaceutical agents
The invention relates to leukotriene-B 4 antagonists of formula I ##STR1## in which n represents a whole number from 2 to 5, X represents a direct bond, 1 to 6 methylene units, an ortho-, meta-...
|
|
|
5514719 |
Fungicidal phenylbenzamides
The invention provides agriculturally useful fungicidal phenylbenzamides of the formula ##STR1## wherein R 1 and R 2 , which are identical or different, are each a hydrogen or halogen atom or an...
|
|
|
5498795 |
Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
Compounds of the formula ##STR1## wherein R 1 -R 3 and R 5 independently are hydrogen, lower alkyl of 1 to 6 carbons, branched chain alkyl or cycloalkyl of 3 to 15 carbons, lower alkyl...
|
|
|
5498792 |
Process of producing N-alkylacetamides
There is disclosed a process of producing an N-alkylacetamide of the general formula (III): ##STR1## wherein X 1 , X 2 and X 3 are the same or different and are independently hydrogen, lower...
|